Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2522094 | 1.00 | ALDH1A1 (0.33) | ALDH1A1DPP4CYP2E1CYP3A4CYP2A6 | |
| SCHEMBL2520199 | 0.80 | KMT2A (0.45) | ALDH1A1MAPTTHRBHPGDRECQL | |
| SCHEMBL2519294 | 0.76 | TUBB4A (0.39) | ALDH1A1MAPTTHRBHPGDRECQL | |
| SCHEMBL2520389 | 0.73 | DPP4 (0.54) | ALDH1A1DPP4MAPTTHRBHPGD | |
| 2,5-Thiophenenedicarboxaldehyde SCHEMBL178830 | 0.72 | — | — | |
| SCHEMBL2514798 | 0.70 | KMT2A (0.51) | ALDH1A1CYP2C19MAPTHPGDKMT2A | |
| SCHEMBL2514796 | 0.70 | KMT2A (0.51) | ALDH1A1CYP2C19MAPTHPGDKMT2A | |
| SCHEMBL2145508 | 0.67 | PIM1 (0.44) | ALDH1A1CYP2A6MAPTHPGDKMT2A | |
| SCHEMBL16533088 | 0.65 | ALDH1A1 (0.43) | ALDH1A1DPP4CYP2E1CYP3A4CYP2A6 | |
| SCHEMBL2145062 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110250254-A1 | ANTIMICROBIAL COMPOSITIONS AND USES | UNIVERSITETET I OLSO (NO) | 2011-10-13 | — | — | US | disclosed |
| US-20110250254-A1 | ANTIMICROBIAL COMPOSITIONS AND USES | UNIVERSITETET I OLSO (NO) | 2011-10-13 | — | — | US | disclosed |
| US-20110250254-A1 | ANTIMICROBIAL COMPOSITIONS AND USES | UNIVERSITETET I OLSO (NO) | 2011-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110250254-A1 | ANTIMICROBIAL COMPOSITIONS AND USES | CBR3, C5, C3AR1 | ALDH1A1 2529/4885DPP4 1304/4885CYP2E1 1571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.